Department of Physics, University of Texas at San Antonio, 78249, USA.
Biophys Chem. 2010 Dec;153(1):97-103. doi: 10.1016/j.bpc.2010.10.008. Epub 2010 Oct 18.
Three sets of in silico experiments have been conducted to elucidate the binding mechanics of two drugs, (+)-methamphetamine (METH) and amphetamine (AMP) to the single-chain variable fragment (scFv) recently engineered from anti-METH monoclonal antibody mAb6H4 (IgG, κlight chain, K(d)=11nM). The first set of in silico experiments are long time equilibration runs of scFv:drug complexes and of drug-free scFv both in the solution. They demonstrate how the solution structures of scFv deviate from its crystallographic form with or without drug molecules bound to it. They lead to the prediction that the Arrhenius activation barrier is nearly zero for transitions from the dissociated state to the bound state. The second set of in silico experiments are nonequilibrium dynamics of pulling the drug molecules out of the binding pocket of scFv and the equilibration runs for drugs to fall back into the binding pocket. They demonstrate that extra water molecules (in addition to the two crystallographic waters) exist inside the binding pocket, underneath the drug molecules. These extra waters must have been evaporated from the binding pockets during the crystallization process of the in vitro experiments of structural determination. The third set of in silico experiments are nonequilibrium steered molecular dynamics simulations to determine the absolute binding free energies of METH and AMP to scFv. The center of mass of a drug molecule (METH or AMP) is steered (pulled) towards (forward) and away from (reverse) the binding site, sampling forward and reverse pulling paths. Mechanic work is measured along the pulling paths. The work measurements are averaged through the Brownian dynamics fluctuation dissipation theorem to produce the free-energy profiles of the scFv:drug complexes as a function of the drug-scFv separation. These experiments lead to the theoretical prediction of absolute binding energies of METH and AMP that are in agreement with the in vitro experimental results.
已经进行了三组计算机实验,以阐明两种药物((+)-甲基苯丙胺(METH)和苯丙胺(AMP)与最近从抗 METH 单克隆抗体 mAb6H4(IgG,κ轻链,K(d)=11nM)工程化的单链可变片段(scFv)结合的机制。第一组计算机实验是 scFv:药物复合物和无药物 scFv 在溶液中的长时间平衡运行。它们展示了 scFv 的溶液结构如何与其晶体形式偏离,无论是否有药物分子与其结合。它们预测从解离状态到结合状态的阿伦尼乌斯活化能垒几乎为零。第二组计算机实验是非平衡动力学,用于将药物分子从 scFv 的结合口袋中拉出,并使药物平衡运行以重新回到结合口袋中。它们表明,在结合口袋中,除了两个晶体水之外,还存在额外的水分子。这些额外的水分子在体外实验的结构确定结晶过程中一定是从结合口袋中蒸发掉了。第三组计算机实验是非平衡导向分子动力学模拟,以确定 METH 和 AMP 与 scFv 的绝对结合自由能。药物分子(METH 或 AMP)的质心被导向(拉动)朝向(向前)和远离(向后)结合位点,沿着向前和向后的拉动路径进行采样。沿着拉动路径测量力学功。通过布朗动力学波动耗散定理对功测量值进行平均,以产生 scFv:药物复合物的自由能曲线作为药物-scFv 分离的函数。这些实验导致了对 METH 和 AMP 的绝对结合能的理论预测,这些预测与体外实验结果一致。